Professor Madrigal is a Distinguished Professor in Hematology and Cellular Therapy (TEC/FEMSA), Professor of Haematology (UCL, UK) and Emeritus Professor (SNI, MX).He is a world leader in Immunotherapy and stem cell transplantation (HSCT), who trained at UNAM, Harvard, Stanford, and University College London (UCL). As a Professor of Haematology at UCL, he has been the Founder and First Scientific Director of the Anthony Nolan Research Institute (ANRI) and the Medical Director of the Cell Therapy Centre for Anthony Nolan.
His research, reflected in more than 500 articles, in journals such as Nature, Nature Genetics, Lancet (cited nearly 18140 times, h-index 70) have contributed to changing the course of immune-cell therapy and HSCT. He has given more than 580 conferences in more than 60 countries and 250 cities and has trained more than two hundred doctors and scientists.He has also been Vice Provost for the America for the University for UCL, and his tireless work has helped create donor registries and Umbilical Cord Banks around the world.He has received the Gold Medal from the British Government. He also has received distinguished memberships from prestigious Academies in Mexico, Spain, Latin America, United States, Russia, Poland, Germany, Ukraine, India and the United Kingdom. He has received five honoris Causa for the Universities of Nottingham, Guadalajara, Odesa, Tartu, Estonia y Timisoara, Rumania.He is an Honorary Member of the British Society of Bone Marrow Transplantation and the Center for International Bone Marrow transplantation, (CIBMTR) in USA. He is an Honorary Member of the German, Austrian Swiss Society of Haemato-Oncology, an Honorary Member of the National Academy of Medicine of Mexico, a Fellow of the Royal College of Physician (FRCP) and a Fellow of the Royal College of Pathology (FRCPath Academy of Medical Science in United Kingdom).He received the Carlos Slim Award and he was awarded the Officer the Most Excellent Order of the British Empire, OBE by her Majesty the Queen in 2022.
